Treatment of congenital lactic acidosis with dichloroacetate

Archives of Disease in Childhood

Volumn 77, Issue 6, 1997, Pages 535-541

  Stacpoole, Peter W ^a,c   Barnes, Carie L ^a   Hurbanis, Matthew D ^a   Cannon, Sterling L ^a   Kerr, Douglas S ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ASCORBIC ACID; BIOTIN; CARNITINE; CYTOCHROME C OXIDASE; DICHLOROACETIC ACID; DIHYDROLIPOAMIDE DEHYDROGENASE; LACTIC ACID; MITOCHONDRIAL DNA; PYRUVATE DEHYDROGENASE COMPLEX; RIBOFLAVIN; THIAMINE; THIOCTIC ACID; TOCOPHEROL; UBIQUINONE; VITAMIN K GROUP;

ADOLESCENT; ADULT; CITRIC ACID CYCLE; CLINICAL ARTICLE; ENZYME DEFICIENCY; FEMALE; GLUCONEOGENESIS; HUMAN; HYPERLACTATEMIA; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LACTIC ACIDOSIS; LIPID DIET; LIVER TOXICITY; MALE; MELAS SYNDROME; MITOCHONDRIAL RESPIRATION; MUTATION; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY; REVIEW;

EID: 0031440630     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.77.6.535     Document Type: Review

References (47)

1. Robinson BH. Lactic acidemia (disorders of pyruvate carboxylase, pyruvate dehydrogenase). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th Ed. New York: McGraw-Hill, 1995: 1479-99.
2. DeVivo DC. The expanding clinical spectrum of mitochondrial diseases. Brain Dev 1993,15:1-22.
3. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In: Scriver CR, Beaudet AL, Sly WS, Vallee D, eds. The metabolic and molecular bases of inherited disease. 7th Ed. New York: McGraw-Hill, 1995: 1535-609.
4. Kerr DS, Wexler ID, Tripatara A, Patel MS. Defects of the human pyruvate dehydrogenase complex. In: Patel MS, Roche T, Harris RA, eds. Alpha keto acid dehydrogenase complexes. Basel: Birkhauser Verlag AG, 1996: 249-70.
5. Stacpoole PW. Lactic acidosis and other mitochondrial disorders. Metabolism 1997,46:306-21.
6. Stacpoole PW. Lactic acidosis. Endocrinol Metab Clin North Am 1993,22:221-45.
7. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992,256:628-32.
8. Kerr DS. Treatment of congenital lactic acidosis: a review. International Pediatrics 1995,10:75-81.
9. Wolf B, Heard GS. Biotinidase deficiency. Adv Pediatr 1991,38:1-21.
10. Falk RE, Cederbaum SD, Blass JP, Gibson GE, Pieter Kark RA, Carrel RE. Ketogenic diet in the management of pyruvate dehydrogenase deficiency. Pediatrics 1976,58:713-21.
11. Wexler ID, Hemalatha SG, McConnell J, et al. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets: studies in patients with identical mutations. Neurology (in press).
12. Stacpoole PW. The pharmacology of dichloroacetate. Metabolism 1989;38:1124-44.
13. Whitehouse S, Cooper RH, Randle PJ. Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem J 1974;141: 761-74.
14. Jackson VN, Halesstrap AP. The kinetics, substrate, and inhibitor specificity of the monocarboxylate (lactate) transporter of rat liver cells determined using the fluorescent intracellular pH indicator, 2′, 7′-bis (carboxyethyl)-5(6)-carboxyfluoroscein. J Biol Chem 1996;271:861-8.
15. Stacpoole PW, Wright EC, Baumgartner TG, et al, and the DCA-Lactic Acidosis Study Group. A controlled trial of dichloroacetate treatment in patients with lactic acidosis. N Engl J Med 1992;327:1564-9.
16. Krishna S, Waller D, ter Kuile F, et al. Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Trans R Soc Trop Med Hyg 1994;88:67-73.
17. Krishna S, Agbenyega T, Angus BJ, et al. Pharmacokinetics and pharmacodynamics of dichloroacetate in children with lactic acidosis due to severe malaria. Q J Med 1995;88:341-9.
18. Holloway PA, Knox K, Bajaj N, et al. Plasmodium berghei infection: dichloroacetate improves survival in rats with lactic acidosis. Exp Parasitol 1995;80:624-32.
19. Saijo T, Naito E, Ito M, Takeda E, Hashimoto T, Kuroda Y. Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. Neuropediatrics 1991;22:166-7.
20. DeVivo DC, Jackson AH, Wade C, Altmann K, Stacpoole PW, DiMauro S. Dichloroacetate treatment of MELAS-associated lactic acidosis. Ann Neurol 1990;28:437-8.
21. Elpeleg ON, Ruitenbeek W, Jakobs C, Barash V, DeVivo DC, Amir N. Congenital lactic acidemia caused by lipoamide dehydrogenase deficiency with favorable outcome. J Pediatr 1995;126:72-4.
22. Burlina AB, Milanesi O, Biban P, et al. Beneficial effect of sodium dichloroacetate in muscle cytochrome C oxidase deficiency. Eur J Pediatr 1993;152:537-41.
23. Evans OB, Stacpoole PW. Brief treatment with dichloroacetate does not modify suspected subacute necrotizing encephalomyelitis. Ann Neurol 1980;8:647-8.
24. Byrd DJ, Krohn HP, Winkler L, et al. Neonatal pyruvate dehydrogenase deficiency with lipoate responsive lactic acidaemia and hyperammonaemia. Eur J Pediatr 1989;148: 543-7.
25. McCormick K, Viscardi RM, Robinson B, Heininger J. Partial pyruvate decarboxylase deficiency with profound lactic acidosis and hyperammonemia: responses to dichloroacetate and benzoate. Am J Med Genet 1985;22:291-9.
26. 1 component of the pyruvate dehydrogenase complex. J Inherit Metab Dis 1988;11:207-17.
27. Kerr DS, Berry SA, Lusk MM, Ho L, Patel MS. A deficiency of both subunits of pyruvate dehydrogenase which is not expressed in fibroblasts. Pediatr Res 1988;24: 95-100.
28. Toth PP, El-Shanti H, Eivens S, Rhead WJ, Klein JM. Transient improvement of congenital lactic acidosis in a male infant with pyruvate decarboxylase deficiency treated with dichloroacetate. J Pediatr 1993;3:427-30.
29. 2 lipoyl trans-acetylase and the X-lipoyl containing component of the pyruvate dehydrogenase complex in patients with lactic acidemia. J Clin Invest 1990;85:1821-4.
30. Robinson BH, Taylor J, Francois B, Beaudet AL, Peterson DF. Lacticacidosis, neurological deterioration and compromised cellular pyruvate oxidation due to a defect in the reoxidation of cytoplasmically generated NADH. Eur J Pediatr 1983;140:98-101.
31. Bonstrany RN, Aprille JR, Halperin J, Levy H, DeLong GR. Mitochondrial cytochrome deficiency presenting as a myopathy with hypotonia, external ophthalmoplegia, and lactic acidosis in an infant and as fatal hepatopathy in a second cousin. Ann Neurol 1983;14:462-70.
32. Oldfors A, Sommerland H, Holme E, Talinius M, Kristiansson B. Cytochrome c oxidase deficiency in infancy. Acta Neuropathol (Berl) 1989;77:267-75.
33. Haworth JC, Robinson BH, Perry Tl. Lactic acidosis due to pyruvate carboxylase deficiency. J Inherit Metab Dis 1981;4:57-8.
34. Okabe I, Kodama H, Shimoizumi H, Kamoshita S, Miyabayashi S. Treatment of lactic acidosis: effects of dichloroacetate on lactate and pyruvate levels in the cerebrospinal fluid. Eur J Pediatr 1986;145:159.
35. Fugii T, Okuno T, Ito M, et al. MELAS of infantile onset: mitochondrial angiopathy or cytopathy? J Neurol Sci 1991; 103:37-41.
36. Dougherty FE, Ernst SG, Aprielle JR. Familial recurrence of atypical symptoms in an extended pedigree with the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like seizure (MELAS). J Pediatr 1994;5:758-61.
37. Kuroda Y, Ito M, Toshima K, et al. Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate. J Inherit Metab Dis 1986;9:244-52.
38. Naito E, Kuroda Y, Toshima K, et al. Effect of sodium dichloroacetate on human pyruvate metabolism. Brain Dev 1989;11:195-7.
39. Coude FX, Saudubray JM, DeMaugre F, Marsac C, Leroux JP. Dichloroacetate as treatment for congenital lactic acidosis. N Engl J Med 1978;299:1365-6.
40. McKhann G, Fancois B, Eurand P. Long term use of low doses of dichloroacetate in a child with congenital lactic acidosis. Pediatr Res 1980;14:167.
41. Kodama H, Yamaguchi S, Okabe I, Kodama M, Orü T, Kamoshita S. Renal effects of dichloroacetate in vivo. Clin Chim Acta 1986;160:265-71.
42. Oldfors A, Tulinius M, Holme E, Kalimo H, Kristianson B, Ericksson BO. Mitochondrial encephalomyopathy. A variant with heart failure and liver steatosis. Acta Neuropathol (Berl) 1987;74:287-93.
43. Robinson J, Norman MG. Feeding problems and lactic acidosis an a 10-week-old boy. Pediatric Neuroscience 1989;15: 28-35.
44. Tulinius MH, Eriksson BO, Hjalmarson O, Holme E, Oldfors A. Mitochondrial myopathy and cardiomyopathy in siblings. Pediatr Neurol 1989;5:182-8.
45. Stacpoole PW, Harwood HJ Jr, Cameron DF, et al. Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats. Fundamental and Applied Pharmacology 1990;14:327-37.
46. De Stefano N, Matthews PM, Ford B, et al. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995;45:1193-8.
47. Aynsley-Green A, Weindling AM, Soltesz G, et al. Dichloroacetate in the treatment of congenital lactic acidosis. J Inherit Metab Dis 1984;7:26.